All In Biotech

Drug Trial Radar · NCT06443463

Long-term Safety and Tolerability of BHV-7000

A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy

Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

660

Planned (sponsor's estimate)

Start

Jul 30, 2024

Primary completion

Dec 2026

Study completion Jan 2027

Sponsor

Lead sponsor
Biohaven Therapeutics Ltd.Industry
Sponsor type
Industry
First posted
Jun 5, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy

Conditions

  • Focal Epilepsy

Interventions

  • BHV-7000Drug

    BHV-7000 50 mg. Participants will take open-label investigational product (IP) once daily

  • BHV-7000Drug

    BHV-7000 75 mg. Participants will take open-label investigational product (IP) once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Deaths, Serious AEs (SAEs), AEs Leading to Study Drug Discontinuation, and moderate or severe AEsTime frame: Up to 104 weeks
  2. Number of Subjects with Clinically Significant Laboratory AbnormalitiesTime frame: Up to 104 weeks

Locations

283 sites in 27 countries. Site status is shown where the registry gives one.

  • Accel Research

    Birmingham, Alabama

  • Onyx Clinical Trials

    Peoria, Arizona

  • Xenoscience, Inc.

    Phoenix, Arizona

  • University of Arizona / Banner University Medical Center Phoenix

    Phoenix, Arizona

  • Barrow Neurological Institute

    Phoenix, Arizona

  • ARENSIA Exploratory Medicine

    Phoenix, Arizona

  • Center for Neurosciences

    Tucson, Arizona

  • Clinical Trials, Inc.

    Little Rock, Arkansas

  • WRN

    Rogers, Arkansas

  • University of California San Diego

    La Jolla, California

  • Amicis Research Center

    Lancaster, California

  • Memorialcare Miller Children's & Women's Hospital Long Beach

    Long Beach, California

  • University of California, Los Angeles

    Los Angeles, California

  • Tri Valley Neurology Medical Associates, Inc.

    Mission Hills, California

  • Stanford University

    Palo Alto, California

  • Profound Research LLC

    Pasadena, California

  • Profound Research LLC

    Poway, California

  • Kaiser Permanente

    Aurora, Colorado

  • University of Colorado Anschultz Medical Campus

    Aurora, Colorado

  • UConn Health

    Farmington, Connecticut

  • Yale School of Medicine - Yale-New Haven Hospital

    New Haven, Connecticut

  • EZR Research LLC

    Boca Raton, Florida

  • Nova Clinical Research, LLC

    Bradenton, Florida

  • Las Mercedes Medical Research

    Hialeah, Florida

  • Coral Clinic Research

    Homestead, Florida

  • University of Florida (Jacksonville)

    Jacksonville, Florida

  • Dm Healthworks

    Kissimmee, Florida

  • University of Miami

    Miami, Florida

  • Y&L Advance Health Care, Inc d/b/a Elite Clinical Research

    Miami, Florida

  • Serenity Research Center

    Miami, Florida

  • Floridian Research Institute

    Miami, Florida

  • AdventHealth Orlando

    Orlando, Florida

  • Research Institute of Orlando

    Orlando, Florida

  • Comprehensive Neurology Clinic

    Orlando, Florida

  • Panhandle Research & Medical Clinic

    Pensacola, Florida

  • Medsol Clinical Research Center

    Port Charlotte, Florida

  • Knight Neurology

    Rockledge, Florida

  • PENS

    Tampa, Florida

  • Santos Research Center

    Tampa, Florida

  • Encore Medical Research of Weston LLC.

    Weston, Florida

Showing 40 of 283 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.